The Clinical Features & Natural History of the Steele-Richardson-Olszewski Syndrome (Prog Supranuclear Palsy)
Neurol 36:1005-1006, Maher,E.R.,et al, 1986
MPTP:A Neurotoxin Relevant to the Pathophysiology of Parkinson's Disease, The 1985 George Cotzias Lecture
Neurol 36:250-258, Snyder,S.H.&D'Amato,R.J., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Subcortical Dementia
BMJ 292:1035-1036, Foster,J.B., 1986
Parkinsonism Following Dystonia in Three Patients
Movement Disorders 1:151-157, Katchen,M.&Duvoisin,R.C., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Dystonia in Untreated Parkinsonism
Clin Neuropharmacol 9:293-297, LeWitt,P.A.,et al, 1986
Neurologic Signs in Senescence
Arch Neurol 42:1154-1157, Jenkyn,L.R.,et al, 1985
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Improved Neurologic Function After Long-Term Correction of Vitamin E Deficiency in Children with Chronic Cholestasis
NEJM 313:1580-1586, Sokol,R.J.,et al, 1985
Neurological Complications in Infants & Children with Acquired Immune Deficiency Syndrome
Ann Neurol 18:560-566, Belman,A.L.,et al, 1985
Giant Cell Arteritis Associated with Mononeuritis Multiplex & Complement-Activating 19S IgM Rheumatoid Factor
Am J Med 79:495-500, Feigal,D.W.,et al, 1985
Syndrome of Palatal Myoclonus & Progressive Ataxia:Two Cases with Magnetic Resonance Imaging
Neurol 35:1212-1214, Sperling,M.R.&Herrman,C., 1985
Pyramidal Tract Deficits & Polyneuropathy in Hyperthyroidism
Am J Med 78:1041-1044, Fisher,M.,et al, 1985
Continuous Intrathecal Baclofen for Severe Spasticity
Lancet 2:125-127, Penn,R.D.&Kroin,J.S., 1985
Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985
Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Reappraisal of Temporary Levodopa Withdrawal ("Drug Holiday") in Parkinson's Disease
NEJM 313:724-728, Mayeux,R.,et al, 1985
"Drug Holiday"in the Treatment of Parkinson's Disease, A Brief Review
Arch Int Med 145:913-915, Friedman,J.H., 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Reversal of Sleep Disturbance in Parkinson's Disease by Antiparkinsonian Therapy:A Preliminary Study
Neurol 35:527-532, Askenasy,J.J.M.,et al, 1985
The Heterogeneity of Parkinson's Disease:Clinical & Prognostic Implications
Neurol 35:522-526, Zetusky,W.J.,et al, 1985
Association Between Essential Tremor & Parkinson's Disease
Ann Neurol 17:329-333, Gereghty,J.J.,et al, 1985
Low Cancer Rates Among Patients with Parkinson's Disease
Ann Neurol 17:505-509, Jansson,B.,et al, 1985
Relapsing Ophthalmoparesis-Sensory Neuropathy Syndrome
Neurol 35:595-596, Kaplan,J.G.,et al, 1985
Radial Compression Neuropathy in Advanced Parkinson's Disease
Arch Neurol 42:695-696, Preston,D.N.,et al, 1985
Severe Compression Neuropathy Following Sudden Onset of Parkinsonian Immobility
Arch Neurol 42:720, Kurlan,R.,et al, 1985
Solitary Cerebellar Metastases, Clinical & Computed Tomographic Correlations
Arch Neurol 42:336-341, Weisberg,L.A., 1985
The Nucleus Basalis of Meynert in Neurological Disease:A Quantitative Morphological Study
Ann Neurol 17:163-170, Rogers,J.D.,et al, 1985
Reversible Parkinsonism Related to Meperidine
NEJM 312:509, Lieberman,A.N.,et al, 1985
Acute Exacerbation of Parkinson's Disease with Sulindac
Ann Neurol 17:104-105, Sandyk,R.,et al, 1985
Ataxic Creutzfeldt-Jakob Disease:Diagnostic Techniques & Neuropathologic Observations in Early Disease
Neurol 35:254-257, Jones,H.R.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
"Apraxia"of Eyelid Opening:An Involuntary Levator Inhibition
Neurol 35:423-427, Lepore,F.E.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Late-Onset Hallervorden-Spatz Disease Presenting as Familial Parkinsonism
Neurol 35:227-234, Jankovic,J.,et al, 1985
Wernicke's Encephalopathy
NEJM 312:1035-1039, Reuler,J.B.,et al, 1985
Cerebellar Infarction in the Superior Cerebellar Artery Distribution
Neurol 35:705-711, Kase,C.S.,et al, 1985
Metachromatic Leukodystrophy Manifesting as a Schizophrenic Disorder:Computed Tomographic Correlation
Ann Neurol 18:94-95, Finelli,P.F., 1985
Subcortical Arteriosclerotic Encephalopathy, (Binswanger's Disease)
Arch Neurol 42:951-959, Kinkel,W.R.,et al, 1985
The Gait Abnormality of Huntington's Disease
Neurol 35:1450-1454, Koller,W.C.&Trimble,J., 1985
Atypical Presentation of Progressive Supranuclear Palsy
Ann Neurol 17:334-343, Davis,P.H.,et al, 1985
Treatment of Progressive Supranuclear Palsy with Tricyclic Antidepressants
Neurol 35:1189-1193, Newman,G.C., 1985
Olivopontocerebellar Atrophy with Dementia, Blindness, & Chorea, Response to Baclofen
Arch Neurol 42:757-758, Trauner,D.A., 1985
The Clinical Syndrome of Striatal Dopamine Deficiency, Parkinsonism Induced by MPTP
NEJM 312:1418-1421, Burns,R.S.,et al, 1985
Permanent Human Parkinsonism Due to 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP) :Seven Cases
Neurol 35:949-956, Ballard,P.A.,et al, 1985
Spinocerebellar Degeneration Associated with a Selective Defect of Vitamin E Absorption
NEJM 313:32-35, Harding,A.E.,et al, 1985
Adrenoleukomyeloneuropathy with Onset in Early Childhood
Ann Neurol 17:311-312, Rosen,N.L.,et al, 1985